Rabin Medical Center ( Site 1602)

Petah Tikva 4941492

2 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Renal Cell, Gastric Neoplasms, Gastroesophageal Junction Adenocarcinoma, Malignant Neoplasms, Von Hippel-Lindau Disease

Studies at this site

• Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043) — Recruiting now
• A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034) — Recruiting now
• Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811) — Completed